Chapter 4

Buyback Engine

For four years Wolters Kluwer returned more than its free cash flow to shareholders, retiring €4.5 billion of stock and lifting per-share earnings faster than profit. That machine ran on the balance sheet: shareholders' equity fell from €2.3 billion to €798 million while net debt climbed to 2.0x EBITDA. For 2026 the buyback is halved to €500 million and cash reinvested into product development — a deliberate step back from the formula, taken at the lowest share price in years.

Returning more than it earned

Across 2022–2025 Wolters Kluwer paid out between roughly 117% and 126% of adjusted free cash flow every year, funding the excess with debt. In 2025 it returned €1.66 billion — €1.1 billion of buybacks plus €563 million of dividends — against €1,348 million of adjusted free cash flow, or about 123% [1] [2].

Source: FY2025 Annual Report — returns and cash conversion p.39 [3]; five-year buyback record p.229 [4].

The buyback has been a standing programme, roughly €1 billion a year, not an opportunistic one. Over 2021–2025 the company spent €4.51 billion to retire 39.1 million shares — about 13% of the count — at an average of €115.35 [5].

Source: FY2025 Annual Report, Share repurchases, cancelations, and issuances 2021–2025 [6].

Paid for out of equity

The returns came from a balance sheet that had room to give and used it. Shareholders' equity fell from €2,310 million at the end of 2022 to €1,749 million in 2023, €1,545 million in 2024, and €798 million in 2025 — a €747 million drop in the final year alone, driven by the buyback and dividends [7] [8]. Over the same window net debt rose from €2,253 million to €4,024 million, lifting net-debt-to-EBITDA from 1.3x to 2.0x [9] [10].

Source: FY2025 Annual Report balance sheet p.42 [11]; FY2024 Annual Report p.40 [12]; FY2023 Annual Report p.41 [13].

Thin book equity overstates the strain. Much of the €798 million figure is an artifact of buying back goodwill-funded shares above their carrying value: each repurchase is charged straight against equity, so a company that returns more than it earns will grind its book value toward zero regardless of how the business performs. The economic anchor is cash, not book capital — €1,348 million of adjusted free cash flow at 103% cash conversion, on 83% recurring revenue [14]. And 2.0x leverage sits inside the stated 1.5x–2.5x policy range, which the company notes has held between 1.3x and 2.4x since 2011 [15]. The constraint is real but not distress: net debt has doubled in three years, and 2.0x is the top half of the range rather than a breach.

What the buyback bought, and at what price

The mechanical payoff is visible in per-share earnings. Diluted adjusted EPS rose 9% in constant currencies in 2025, of which about a third came not from profit but from a 3% reduction in the diluted share count, to 231.8 million [16]. Repeated over a decade, that share-count shrinkage is a meaningful slice of the double-digit EPS compounding the equity story leans on (Compounder Repriced).

The price paid is the harder part. The average repurchase price climbed with the shares — €82.62 in 2021, €98.75, €114.44, then €149.23 in 2024 and €128.45 in 2025 — so the heaviest euro-spend went in near the top [17]. At €57.62 in early July 2026, the 39.1 million shares bought for €4.51 billion are worth about €2.27 billion. That is not a profit-and-loss loss — a buyback is a transfer to the sellers, not a mark-to-market position — but it is the record of a formulaic programme that could not, and did not, time the stock. Wolters Kluwer's own market capitalisation fell from €38.3 billion to €20.5 billion over 2025 [18].

One fact cuts the other way, and management makes it explicitly. As the shares fell in the second half of 2025, it accelerated the programme — completing the 2025 buyback two months early and pulling roughly €200 million of the 2026 plan forward into late 2025 "in light of the share price development" [19]. So the company leaned into weakness rather than away from it. The critique is not that it bought high on purpose, but that a standing €1-billion programme, by construction, deploys most capital when the price and the multiple are highest.

The 2026 step back

The 2026 plan is where the formula visibly bends. The intended buyback is cut to "up to €500 million," half of 2025's €1.1 billion, while annual product-development spending is lifted from 11% of revenue (about €650 million) to 12–13% "in 2026 and beyond" to fund the AI response [20] [21]. The dividend is untouched and still progressive: the 2025 total rises 8% to €2.52 per share [22]. The stated order of claims on cash is explicit — dividend first, then organic investment, then selective acquisitions, with the buyback the residual [23].

The arithmetic of the pivot: with 2026 adjusted free cash flow guided to €1,300–1,350 million, a €500 million buyback plus a dividend near €580 million takes total returns to roughly 82% of free cash flow — below 100% for the first time in years, letting leverage drift back down as EBITDA grows [24].

Sources: buybacks and cash conversion, FY2025 Annual Report pp.39, 201, 229 [25] [26]; 2026 free-cash-flow and buyback guidance p.15 [27]. 2026 returns estimated (€500m buyback plus dividend held on the progressive policy); earlier years are cash dividends paid plus buyback consideration.

Guidance for 2026 is another year of good organic growth, margin rising toward 28.0%, and high-single-digit diluted-adjusted-EPS growth in constant currencies — a step down from the 9–11% range of recent years, consistent with a smaller buyback contribution [28]. The EPS algorithm is being rebalanced from financial engineering toward reinvestment, not abandoned.

The read

The capital-return record is disciplined in design and procyclical in outcome. A standing programme retired 13% of the shares and added a third of recent EPS growth, but deployed €4.5 billion at an average price now roughly double the market, and it is being throttled just as the stock reaches its cheapest multiple in years (Ten Times Earnings). The strongest fact against reading the cut as a misstep is that management accelerated buybacks into the 2025 decline and has kept 2.0x leverage inside a policy band it has respected for over a decade — this is a reallocation, not a retreat forced by stress.

What separates prudence from error is whether the reinvestment earns its keep. Buying back stock at €57.62 is a high-return use of cash — the shares carry a free-cash-flow yield above 10% (Ten Times Earnings) — so steering roughly €600 million a year of incremental buyback capacity and product-development spend into the AI build only adds value if that spend lifts organic growth above where the maintained-buyback path would have left it. The first clean read on whether it is working comes with the H1-2026 results on 5 August 2026; until then the reallocation is a claim, not a result.

One alignment note supports management's framing rather than undercutting it: the 2023–2025 long-term incentive plan paid out below target, including a zero payout on the relative-total-shareholder-return measure, because the share-price collapse dragged Wolters Kluwer to fifteenth among its TSR peer group [29]. The people steering capital allocation felt the derating in their own pay.